Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: Dopamine hydrochloride |
Click to Show/Hide the Full List of HOSPPI: 7 HOSPPI
|
Catechol O-methyltransferase (COMT) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0043
DME Info
|
Uniprot ID |
|
Interaction Name |
COMT-dadH interaction |
[1], [2] |
Description |
The interaction, between human Catechol O-methyltransferase and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 1A2 (CYP1A2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0003
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP1A2-dadH interaction |
[1], [3] |
Description |
The interaction, between human Cytochrome P450 1A2 and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 2C9 (CYP2C9) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0019
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2C9-dadH interaction |
[1], [4] |
Description |
The interaction, between human Cytochrome P450 2C9 and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 2D6 (CYP2D6) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0009
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2D6-dadH interaction |
[1], [4] |
Description |
The interaction, between human Cytochrome P450 2D6 and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Mephenytoin 4-hydroxylase (CYP2C19) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0021
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2C19-dadH interaction |
[1], [4] |
Description |
The interaction, between human Mephenytoin 4-hydroxylase and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Monoamine oxidase type B (MAO-B) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0045
DME Info
|
Uniprot ID |
|
Interaction Name |
MAO-B-dadH interaction |
[1], [5] |
Description |
The interaction, between human Monoamine oxidase type B and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Sulfotransferase 1B1 (SULT1B1) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0380
DME Info
|
Uniprot ID |
|
Interaction Name |
SULT1B1-dadH interaction |
[1], [6] |
Description |
The interaction, between human Sulfotransferase 1B1 and Dopamine dehydroxylase from Eggerthella lenta which collectively metabolize the drug Dopamine hydrochloride, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|